News & Insights
Professionals
Focus Areas
Regions
Type
Sort By
Client News 1 result
Client News
|December 11, 2025
Contineum Therapeutics Announces Pricing of Upsized $90M Public Offering
Contineum Therapeutics, a clinical-stage biopharmaceutical company, announces the pricing of an upsized underwritten public offering of 7,346,938 shares of its Class A common stock at a public offering price of $12.25 per share.